Promoter holding
64.27%
AL
Alpine Lifescience Private Limited - Due diligence report
A 360° intelligence report on Alpine Lifescience Private Limited: trust score, financial health, credit view, compliance, directors, growth …
AL
Alpine Lifescience Private Limited
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Alpine Lifescience Private Limited — 360° Intelligence Report
Generated from MCA filings & public records85/100
Trust Score
Low Risk
Alpine Lifescience Private Limited is assessed as Low Risk with a Trust Score of 85/100. Alpine Lifescience Private Limited is an active private limited indian non-government company incorporated in 2019, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 09 Jul 2026 from the latest processed filings. Alpine Lifescience Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
85/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 4 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 50/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- No open charges - unencumbered balance sheet.
- Elevated gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 88/100 Low Risk
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| MADHULIKA UPENDRA KUMAR SINGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SITA KHARYA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ARIHANT SURANA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 1 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 80 · Distress 80
Growth signals & trust indicators
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Net margin improved to 61%.
Operating for 6 years.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 38% in a year.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence85/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view81/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 10 events30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
31 Mar 2023
Share transfer (FY 2023)
1000.00000000 shares to Sita Kharya
12 Nov 2021
Director ceased
SITA KHARYA
Director ceased
ARIHANT SURANA
28 Oct 2021
Director appointed
ARIHANT SURANA (Director)
07 May 2021
Director appointed
SITA KHARYA (Director)
18 Jun 2020
Director ceased
GAURAV KHARYA
28 Aug 2019
Incorporated
Registered with Roc Delhi
Director appointed
MADHULIKA UPENDRA KUMAR SINGH (Director)
10
Key Observations
Auto-generated from the data aboveDebt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
| Company | CIN | Location |
|---|---|---|
| Abhinav Mri & Diagnostics Private Limited | U85195PN2010PTC136909 | Pune, Maharashtra, India |
| Izara Health Care Private Limited | U85100KL2022PTC074722 | Alappuzha, Kerala, India |
| Medoplus | U74999UP2020PTC135683 | Noida, Uttar Pradesh, India |
| Healthkon | U74900TG2015PTC101477 | Hyderabad, Telangana, India |
| Quick Book | U74999AS2018PTC018505 | Silchar, Assam, India |
| Alpine Rehabilitations Private Limited | U33111UP2012PTC051704 | Moradabad, Uttar Pradesh, India |
| Manasa Neuropsychiatric Hospital | U85110KA1994PTC016783 | Bangalore, Karnataka, India |
| Dr. Ankur Gupta Spine Clinic Private Limited | U85110UP2022PTC160055 | Kanpur, Uttar Pradesh, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Alpine Lifescience Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Alpine Lifescience Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Alpine Lifescience Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether Alpine Lifescience Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Alpine Lifescience Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Alpine Lifescience Private Limited an active company?
Alpine Lifescience Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Alpine Lifescience Private Limited financially healthy?
Alpine Lifescience Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.
Should I do business with Alpine Lifescience Private Limited?
Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Alpine Lifescience Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Alpine Lifescience Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Alpine Lifescience Private Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Alpine Lifescience Private Limited?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
